DSIP: what is known about delta sleep-inducing peptide?
Clinical review pending
DSIP is marketed for sleep and stress, but a human benefit is not reliably established. Its history, proposed mechanisms and limited research.
There is no reliable human evidence so far for DSIP as a treatment for sleep problems or stress. Although the peptide is sold for these purposes, the few older human studies produced inconsistent results. A benefit reliably confirmed in further studies has not been demonstrated. DSIP’s role in the body also remains unclear.
What is DSIP?
DSIP stands for “delta sleep-inducing peptide.” A peptide is a chain of amino acids; DSIP contains nine. Researchers first isolated it decades ago from the blood of sleeping rabbits. Wellness sellers and suppliers of so-called research peptides market DSIP for sleep and stress. Its function in the body is poorly understood, however, and it is not an approved medicine.
How was DSIP discovered?
The discovery of DSIP in the 1970s began with a question in sleep research: is there a substance in the blood that induces sleep? To investigate, the Switzerland-based physiologist Marcel Monnier and his colleagues connected the circulatory systems of rabbits. They electrically stimulated a sleep-related brain region in one animal and passed its blood to a second. The second animal’s brain then showed slow, high-amplitude waves. These delta waves are characteristic of deep sleep. The experiment suggested that a sleep-promoting substance had reached the second animal through the blood.
In 1977, Guido Schoenenberger, Monnier and their colleagues isolated this substance and produced it synthetically (1). The peptide consisted of nine amino acids. Because the researchers associated it with delta-wave sleep, they called it “delta sleep-inducing peptide.” Producing it synthetically allowed them to study it further.
In the decades that followed, researchers also investigated whether DSIP plays a role in stress, body temperature, pain and antioxidant processes. Despite nearly fifty years of research, neither a confirmed mechanism of action nor an approved therapy has emerged. DSIP remains experimental.
How does DSIP work?
How DSIP works has not been established. Several possible functions are being investigated:
- DSIP might be involved in sleep regulation.
- It might influence the physical stress response through the hypothalamic-pituitary-adrenal axis. This connection between the brain and adrenal glands, known as the HPA axis, controls the hormonal stress response.
- An antioxidant effect, meaning an effect against oxidative processes, is also under discussion.
A receptor through which DSIP binds and exerts its effects has not been confirmed. Even the sleep association that gave the peptide its name comes from early animal experiments. These do not reliably explain how, or whether, DSIP affects human sleep. Its proposed functions do not establish a health benefit.
Is DSIP FDA-approved?
No. DSIP is not approved by the US Food and Drug Administration. Its availability as a “research peptide” says nothing about approval as a medicine.
What does the research show?
Only a few older studies have examined DSIP in humans. Work from the 1980s and 1990s investigated insomnia (2), chronic pain (3) and withdrawal states (4). The findings were inconsistent. Most studies were small and lacked a control group. Without such a comparison group, it is difficult to judge whether observed changes are actually due to DSIP.
A benefit repeatedly confirmed in modern, well-conducted studies has not been demonstrated. A reliable basis for using DSIP to improve sleep or relieve stress is therefore missing.